Sarepta shares get outperform rating on Elevidys approval By Investing.com
On Thursday, Sarepta Therapeutics (NASDAQ:) shares obtained a optimistic outlook from Raymond James as protection was resumed with an Outperform ...
Tag: Elevidys
On Thursday, Sarepta Therapeutics (NASDAQ:) shares obtained a optimistic outlook from Raymond James as protection was resumed with an Outperform ...